Literature DB >> 21911464

Immunization with apoptotic phagocytes containing Histoplasma capsulatum activates functional CD8(+) T cells to protect against histoplasmosis.

Shih-Hung Hsieh1, Jr-Shiuan Lin, Juin-Hua Huang, Shang-Yang Wu, Ching-Liang Chu, John T Kung, Betty A Wu-Hsieh.   

Abstract

We have previously revealed the protective role of CD8(+) T cells in host defense against Histoplasma capsulatum in animals with CD4(+) T cell deficiency and demonstrated that sensitized CD8(+) T cells are restimulated in vitro by dendritic cells that have ingested apoptotic macrophage-associated Histoplasma antigen. Here we show that immunization with apoptotic phagocytes containing heat-killed Histoplasma efficiently activated functional CD8(+) T cells whose contribution was equal to that of CD4(+) T cells in protection against Histoplasma challenge. Inhibition of macrophage apoptosis due to inducible nitric oxide synthase (iNOS) deficiency or by caspase inhibitor treatment dampened the CD8(+) T cell but not the CD4(+) T cell response to pulmonary Histoplasma infection. In mice subcutaneously immunized with viable Histoplasma yeasts whose CD8(+) T cells are protective against Histoplasma challenge, there was heavy granulocyte and macrophage infiltration and the infiltrating cells became apoptotic. In mice subcutaneously immunized with carboxyfluorescein diacetate succinimidyl ester (CFSE)-labeled apoptotic macrophages containing heat-killed Histoplasma, the CFSE-labeled macrophage material was found to localize within dendritic cells in the draining lymph node. Moreover, depleting dendritic cells in immunized CD11c-DTR mice significantly reduced CD8(+) T cell activation. Taken together, our results revealed that phagocyte apoptosis in the Histoplasma-infected host is associated with CD8(+) T cell activation and that immunization with apoptotic phagocytes containing heat-killed Histoplasma efficiently evokes a protective CD8(+) T cell response. These results suggest that employing apoptotic phagocytes as antigen donor cells is a viable approach for the development of efficacious vaccines to elicit strong CD8(+) T cell as well as CD4(+) T cell responses to Histoplasma infection.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21911464      PMCID: PMC3257918          DOI: 10.1128/IAI.05350-11

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  33 in total

1.  Dendritic cells containing apoptotic melanoma cells prime human CD8+ T cells for efficient tumor cell lysis.

Authors:  L Jenne; J F Arrighi; H Jonuleit; J H Saurat; C Hauser
Journal:  Cancer Res       Date:  2000-08-15       Impact factor: 12.701

2.  In vivo depletion of CD11c+ dendritic cells abrogates priming of CD8+ T cells by exogenous cell-associated antigens.

Authors:  Steffen Jung; Derya Unutmaz; Phillip Wong; Gen-Ichiro Sano; Kenia De los Santos; Tim Sparwasser; Shengji Wu; Sri Vuthoori; Kyung Ko; Fidel Zavala; Eric G Pamer; Dan R Littman; Richard A Lang
Journal:  Immunity       Date:  2002-08       Impact factor: 31.745

Review 3.  Apoptosis paves the detour path for CD8 T cell activation against intracellular bacteria.

Authors:  Florian Winau; Stefan H E Kaufmann; Ulrich E Schaible
Journal:  Cell Microbiol       Date:  2004-07       Impact factor: 3.715

Review 4.  Cross-priming in health and disease.

Authors:  Christian Kurts; Bruce W S Robinson; Percy A Knolle
Journal:  Nat Rev Immunol       Date:  2010-06       Impact factor: 53.106

5.  Tumor-derived exosomes are a source of shared tumor rejection antigens for CTL cross-priming.

Authors:  J Wolfers; A Lozier; G Raposo; A Regnault; C Théry; C Masurier; C Flament; S Pouzieux; F Faure; T Tursz; E Angevin; S Amigorena; L Zitvogel
Journal:  Nat Med       Date:  2001-03       Impact factor: 53.440

6.  Functional T cells in primary immune response to histoplasmosis.

Authors:  Jr-Shiuan Lin; Betty A Wu-Hsieh
Journal:  Int Immunol       Date:  2004-09-27       Impact factor: 4.823

7.  Apoptosis facilitates antigen presentation to T lymphocytes through MHC-I and CD1 in tuberculosis.

Authors:  Ulrich E Schaible; Florian Winau; Peter A Sieling; Karsten Fischer; Helen L Collins; Kristine Hagens; Robert L Modlin; Volker Brinkmann; Stefan H E Kaufmann
Journal:  Nat Med       Date:  2003-07-20       Impact factor: 53.440

8.  RNA interference in Histoplasma capsulatum demonstrates a role for alpha-(1,3)-glucan in virulence.

Authors:  Chad A Rappleye; Jacquelyn T Engle; William E Goldman
Journal:  Mol Microbiol       Date:  2004-07       Impact factor: 3.501

9.  Salmonella-induced apoptosis of infected macrophages results in presentation of a bacteria-encoded antigen after uptake by bystander dendritic cells.

Authors:  U Yrlid; M J Wick
Journal:  J Exp Med       Date:  2000-02-21       Impact factor: 14.307

10.  Vaccine immunity to pathogenic fungi overcomes the requirement for CD4 help in exogenous antigen presentation to CD8+ T cells: implications for vaccine development in immune-deficient hosts.

Authors:  Marcel Wuthrich; Hanna I Filutowicz; Tom Warner; George S Deepe; Bruce S Klein
Journal:  J Exp Med       Date:  2003-06-02       Impact factor: 14.307

View more
  9 in total

Review 1.  Dendritic cell interactions with Histoplasma and Paracoccidioides.

Authors:  Sharanjeet K Thind; Carlos P Taborda; Joshua D Nosanchuk
Journal:  Virulence       Date:  2015-05-01       Impact factor: 5.882

Review 2.  Dendritic cells in antifungal immunity and vaccine design.

Authors:  René M Roy; Bruce S Klein
Journal:  Cell Host Microbe       Date:  2012-05-17       Impact factor: 21.023

Review 3.  Adaptive immunity to fungi.

Authors:  Akash Verma; Marcel Wüthrich; George Deepe; Bruce Klein
Journal:  Cold Spring Harb Perspect Med       Date:  2014-11-06       Impact factor: 6.915

4.  Immunization Strategies for the Control of Histoplasmosis.

Authors:  Maxwell T Roth; Daniel Zamith-Miranda; Joshua D Nosanchuk
Journal:  Curr Trop Med Rep       Date:  2019-03-26

Review 5.  Fungal cell wall vaccines: an update.

Authors:  John E Edwards
Journal:  J Med Microbiol       Date:  2012-01-19       Impact factor: 2.472

Review 6.  Antifungal Resistance, Metabolic Routes as Drug Targets, and New Antifungal Agents: An Overview about Endemic Dimorphic Fungi.

Authors:  Juliana Alves Parente-Rocha; Alexandre Melo Bailão; André Correa Amaral; Carlos Pelleschi Taborda; Juliano Domiraci Paccez; Clayton Luiz Borges; Maristela Pereira
Journal:  Mediators Inflamm       Date:  2017-06-13       Impact factor: 4.711

Review 7.  Antifungal Therapy: New Advances in the Understanding and Treatment of Mycosis.

Authors:  Liliana Scorzoni; Ana C A de Paula E Silva; Caroline M Marcos; Patrícia A Assato; Wanessa C M A de Melo; Haroldo C de Oliveira; Caroline B Costa-Orlandi; Maria J S Mendes-Giannini; Ana M Fusco-Almeida
Journal:  Front Microbiol       Date:  2017-01-23       Impact factor: 5.640

8.  An Intracellular Arrangement of Histoplasma capsulatum Yeast-Aggregates Generates Nuclear Damage to the Cultured Murine Alveolar Macrophages.

Authors:  Nayla de Souza Pitangui; Janaina de Cássia Orlandi Sardi; Aline R Voltan; Claudia T Dos Santos; Julhiany de Fátima da Silva; Rosangela A M da Silva; Felipe O Souza; Christiane P Soares; Gabriela Rodríguez-Arellanes; Maria Lucia Taylor; Maria J S Mendes-Giannini; Ana M Fusco-Almeida
Journal:  Front Microbiol       Date:  2016-01-11       Impact factor: 5.640

9.  Induction of Apoptosis in Toxoplasma gondii Infected Hela Cells by Cisplatin and Sodium Azide and Isolation of Apoptotic Bodies and Potential Use for Vaccination against Toxoplasma gondii.

Authors:  Kourosh Cheraghipour; Laleh Shariati; Hossein Khanahmad; Mazdak Ganjalikhani-Hakemi; Abbas Moridnia; Mina Mirian; Nader Pestehchian
Journal:  Iran J Parasitol       Date:  2018 Jul-Sep       Impact factor: 1.012

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.